We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urinary Biomarkers Diagnose Serious Kidney Allergic Reaction

By LabMedica International staff writers
Posted on 27 May 2019
Acute interstitial nephritis is a condition marked by inflammation and swelling of the renal tubules, the tiny portals in the kidneys where blood is filtered. More...
As a result, the tubules cannot properly reabsorb water and useful organic substances, such as glucose and amino acids, or secrete waste products such as urea and creatinine into urine.

Acute interstitial nephritis (AIN) is commonly the result of autoimmune diseases or allergic reactions to more than 100 medications, including antibiotics, pain relievers and antacids. The disease is estimated to cause 15% to 20% of all hospitalizations for acute kidney injury. Currently, the only method of diagnosing AIN is by examining renal tissue obtained with a biopsy, putting patients at some risk from complications.

A large team of scientists collaborating with Johns Hopkins Medicine (Baltimore, MD, USA) prospectively enrolled participants who were scheduled to undergo a clinically indicated kidney biopsy at two Yale University–affiliated hospitals from January 2015 to June 2018. Three renal pathologists independently evaluated biopsy slides to establish AIN diagnosis.

The investigators measured the amounts of 12 urine and 10 blood plasma proteins in samples from 79 adult, biopsy-confirmed AIN patients, and compared them to the amounts in 186 adult kidney biopsy patients without an AIN diagnosis. The scientists measured biomarkers from plasma and urine samples stored at -80 ºC after a single controlled thaw.

The team used the manufacturer-validated 10-plex Proinflammatory Panel 1 to test plasma cytokines and validated the above 10-plex panel in the urine. They also created and validated a custom 2-plex urine assay for IL-5 and IL-9.

The team also performed urine albumin and creatinine measurements using Randox RX Daytona machine and urine dipstick analysis using Clinitek Status analyzer. They also performed urine sediment microscopy using a Laxco LMC4BF.

The results, reviewed independently by three pathologists, showed that none of the plasma biomarkers were associated with AIN, but that two proteins, tumor necrosis factor-alpha (TNF-α) and interluken-9 (IL-9), were consistently seen in the urine of AIN patients. Neither cytokine was present in the control samples, either in plasma or urine. To test the sensitivity of using IL-9 in this manner, the scientists compared its AIN-detecting ability in patients whose disease was confirmed by pathologists who evaluated biopsied material or was symptomatically diagnosed by clinicians prior to the biopsies.

Chirag Parikh, PhD, a nephrologist and senior author of the study said, “Because both cytokines are seen in allergic diseases such as atopic dermatitis and food allergies, and AIN most often is the result of an allergic response, it makes sense to consider using them as diagnostic tools. If biopsy diagnoses are considered 100% accurate, then IL-9 had a very comparable ranking of 84%, and this was significantly better than the 62% to 69% achieved by clinicians without biopsies.” The study was published on May 16, 2019, in the Journal of Clinical Investigation Insight.

Related Links:
Johns Hopkins Medicine


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.